Compare Adaptive Biotechnologies Corp (ADPT) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Weibo Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2.1× Weibo Corp's market cap, and Weibo Corp pays a 7.75% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | WB | |
|---|---|---|
Market Cap | $4.04B | $1.93B |
Sector | Health | Media |
52-Week High | $25.45 | $12.83 |
52-Week Low | $12.30 | $7.20 |
Enterprise Value | $4.10B | $1.20B |
Dividend Yield | — | 7.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
